Author Affiliations: Division of Maternal-Fetal Medicine (Dr Stuebe) and Obstetrics and Gynecology Epidemiology Center (Drs Xue and Michels), Department of Obstetrics, Gynecology, and Reproductive Biology and Channing Laboratory, Department of Medicine (Drs Willet and Michels), Brigham and Women's Hospital and Harvard Medical School, and Departments of Nutrition (Dr Willet) and Epidemiology (Dr Michels), Harvard School of Public Health, Boston, Massachusetts. Dr Stuebe is now with the Department of Maternal-Fetal Medicine, University of North Carolina at Chapel Hill.
Findings from observational studies suggest an inverse association between lactation and premenopausal breast cancer risk, but results are inconsistent, and data from large prospective cohort studies are lacking.
We used information from 60 075 parous women participating in the prospective cohort study of the Nurses' Health Study II from 1997 to 2005. Our primary outcome was incident premenopausal breast cancer.
We ascertained 608 incident cases of premenopausal breast cancer during 357 556 person-years of follow-up. Women who had ever breastfed had a covariate-adjusted hazard ratio (HR) of 0.75 (95% confidence interval [CI], 0.56-1.00) for premenopausal breast cancer compared with women who had never breastfed. No linear trend was found with duration of total lactation (P = .95), exclusive lactation (P = .74), or lactation amenorrhea (P = .88). The association between lactation and premenopausal breast cancer was modified by family history of breast cancer (P value for interaction = .03). Among women with a first-degree relative with breast cancer, those who had ever breastfed had a covariate-adjusted HR of 0.41 (95% CI, 0.22-0.75) for premenopausal breast cancer compared with women who had never breastfed, whereas no association was observed among women without a family history of breast cancer.
In this large, prospective cohort study of parous premenopausal women, having ever breastfed was inversely associated with incidence of breast cancer among women with a family history of breast cancer.
Worldwide, more women develop breast cancer than any other malignant disease. Established risk factors include early age at menarche, nulliparity, late age at first birth, and family history.
Some studies have suggested that breastfeeding reduces breast cancer risk, but evidence has been mixed. Observational studies relating lactation and breast cancer among postmenopausal women have largely failed to identify an association.1,2 Reports from case-control studies suggest a modest inverse association between breastfeeding and premenopausal breast cancer risk, but findings have been inconsistent and limited by the potential for recall bias.3,4 Longitudinal studies have produced conflicting results.1,2,5- 7 These discrepant findings have been attributed to differences in intensity of breastfeeding among study populations.8 This hypothesis has not been tested because prior prospective studies have not collected information on supplemental feeding or duration of amenorrhea.
To assess the relationship between breastfeeding intensity and incidence of premenopausal breast cancer, we collected detailed information on lactation history, supplemental feeding, and lactation amenorrhea among participants in the Nurses' Health Study II, a large prospective study on women's health.
The Nurses' Health Study II (NHS II) began in 1989, enrolling 116 608 women from 14 US states. Participants were 25 to 42 years of age at baseline, and 90% reported their primary ancestry as white. All participants were registered nurses; in 2001, the most common category of reported pretax household income was $75 000 to $100 000 per year. Among participants who were married, more than half of their husbands had completed a 4-year college or graduate degree.
Each woman completed a detailed questionnaire on demographic, anthropometric, and lifestyle factors, with follow-up questionnaires every 2 years. For the current analyses, we restricted the study population to women who had reported at least 1 pregnancy in 1997, when breastfeeding was assessed in detail (Figure). Women who were nulliparous or missing data on parity in 1997 (n = 41 882) or did not report breastfeeding history (n = 841) were excluded at baseline. We further excluded women who were postmenopausal (n = 6962) or whose menopausal status was unknown (n = 3479), as well as those with prevalent breast cancer (n = 515), carcinoma in situ (n = 118) or other malignant diseases (n = 2451), missing year of first birth (n = 670), or missing height (n = 89), leaving 60 075 NHS II participants for the current analyses.
Consort diagram. The asterisk indicates that we excluded from follow-up participants who reported another birth, became postmenopausal, were diagnosed as having incident invasive breast cancer or carcinoma in situ, or died. The dagger indicates that we excluded from the current follow-up women with unknown menopausal status or missing body mass index (BMI) or parity data.
At baseline in 1989 and on each biennial questionnaire, women reported the number of pregnancies lasting 6 months or more. In 1997, participants completed a detailed questionnaire on breastfeeding and use of medication to suppress lactation for each of their first 4 children. Women with more than 4 children reported total months of breastfeeding across all additional pregnancies. All durations were reported as categorical variables. For assessment of total duration, women were asked, “If you breastfed, at what month did you stop breastfeeding altogether?” For assessment of exclusive duration, women were asked, “At what month did you start giving formula or purchased milk at least once daily?” and “At what month did you start giving solid food at least once daily (baby food, cereal, table food, etc)?” Exclusive duration was defined as the earlier of these 2 time points. For assessment of lactation amenorrhea, women were asked, “At what month after delivery did your menstrual periods return?” If a woman conceived another pregnancy prior to resuming menses, duration of amenorrhea was coded as missing for the index birth. For each definition, contributions from all pregnancies were summed to determine lifetime duration. To assess use of medications to suppress lactation, women were asked “Did you use any medication to suppress lactation?” Options for response were “pills for 1 to 2 days only,” “pills for more than 2 days,” “injection,” or “no.”
On each biennial questionnaire, participants were asked to report whether they had been newly diagnosed as having breast cancer and when the diagnosis was made. Study staff routinely search the National Death Index for women who have not responded to questionnaires. Women diagnosed as having breast cancer (or, for deceased participants, the next of kin) were asked for permission to review medical records and confirm the diagnosis. We confirmed self-reported breast cancer for more than 99% of women whose medical records were obtained. Because self-reports of breast cancer are very reliable in our cohort, we included in our analysis self-reported cases for which medical records could not be obtained (n = 72 [12% of cases]). Cases of carcinoma in situ were censored from the analysis. Our analysis was limited to incident cases of invasive breast cancer diagnosed from 1997 through 2005.
The following time-fixed covariates were included in our multivariate-adjusted model: age at menarche, weight at age 18 years, and current height and weight were reported on the enrollment survey in 1989. Birth weight of the participant was reported in 1991. Family history of breast cancer was assessed in 1989, 1997, and 2001, when each participant reported whether her mother, 1 or 2 sisters, or maternal or paternal grandmother had been diagnosed as having breast cancer. Although family history was reported at multiple time points, we used the cumulative report of family history as of 2001 as a time-fixed covariate in our models because genetic transmission of risk does not vary over time.
Time-varying covariate data were collected on multiple questionnaires. On each biennial questionnaire, women reported current weight, personal history of benign breast disease, menopausal status, and oral contraceptive use. Women reported alcohol consumption in 1991, 1995, 1999, and 2003. Physical activity data were collected in 1989, 1991, 1997, and 1999. Women reported number of hours per week engaged in a specified list of activities. These data were used to compute a total activity score based on metabolic equivalents (METs) per week of physical activity.9 The most updated values of the time-varying covariates were used in the statistical analysis.
The relative risk of premenopausal breast cancer by lactation history was assessed with a Cox proportional hazards model. We evaluated proportionality of hazards by assessing the interactions between ever breastfeeding and both follow-up period and time since last birth. Women contributed person-years of follow-up from 1997 until reaching menopause, diagnosis of breast cancer, death, or the study end date of June 2005. We excluded from follow-up those participants whose menopausal status or parity was unknown until updated information was available. We censored participants if they reported a birth after 1997 to limit our analysis to prospectively reported lactation. To ensure that such censoring did not bias our results, we performed a sensitivity analysis in which we retained participants who gave birth after 1997 without updating lactation history.
Because lactation duration was reported categorically, we modeled our primary analysis using categorical variables. We used midpoints of categories to assess linear trends. Two-sided P values are reported for trends, and 95% confidence intervals (CIs) are reported for hazard ratio (HR) estimates.
All models are adjusted for age and follow-up time in months. In our covariate-adjusted analysis, we included only a priori risk factors for breast cancer to avoid overfitting of the model. The following variables were included: height, body mass index (BMI), BMI at age 18 years, and year of first birth (continuous); family history of first- or second-degree relative with breast cancer, history of benign breast disease, and use of medications to suppress lactation (dichotomous); and birth weight of participant, age at menarche, parity, and age at first birth; physical activity; alcohol consumption; and oral contraceptive use (categorical). Menopausal status, BMI, oral contraceptive use, and history of benign breast disease were updated at 2-year intervals.
To differentiate between the effects of parity and lactation, we conducted additional analyses restricted to women with only 1 child. Effect modification by family history of a first-degree relative with breast cancer, parity, and age at first birth were evaluated by adding a cross-product term and comparing regression models with a likelihood ratio test. All analyses were performed using SAS statistical software (version 9.1; SAS Institute Inc, Cary, North Carolina). The study was approved by the institutional review boards of the Harvard School of Public Health and the Brigham and Women's Hospital, Boston, Massachusetts.
Of the 60 075 premenopausal, parous women who were eligible for participation in our analysis, 87% had ever breastfed. Longer lifetime durations of breastfeeding were associated with higher parity and lower oral contraceptive use (Table 1). Duration of breastfeeding was inversely associated with history of benign breast disease. In addition, women who breastfed for longer durations were thinner both at age 18 years and during study follow-up than women who breastfed for shorter durations.
Use of medication to suppress lactation was common in our cohort, with 72.2% of never-breastfeeders reporting suppression. Women who had never breastfed and had suppressed lactation were younger at their first birth and had more children than women who neither breastfed nor suppressed lactation.
A total of 608 cases of incident premenopausal breast cancer were diagnosed during 357 556 person-years of follow-up, with a mean age at diagnosis of 46.2 years. We found a lower incidence of premenopausal breast cancer among women who had ever breastfed (covariate-adjusted HR, 0.75; 95% CI, 0.56-1.00) than among women who had never breastfed; however, we found no association with duration of lactation (Table 2) (P value for linear trend = .95).
To test for proportionality of hazards, we used interaction terms between ever-breastfeeding and both time since last birth and follow-up period. We found no evidence of effect modification in our models (ever breastfed and time since last birth interaction, P = .57; ever breastfed and follow-up period interaction, P = .93).
The association between lactation and incident breast cancer seemed to be stronger among women with only 1 birth. In this subgroup, ever having breastfed was associated with a covariate-adjusted HR of 0.50 (95% CI, 0.28-0.91) compared with never having breastfed; however, the difference in association between women with only 1 birth and those with 2 or more births was not statistically significant (P value for 1 child and ever breastfed interaction = .26). We found no association in this subgroup with duration of lactation (Table 3) (P value for linear trend = .50).
We further examined the associations between exclusive breastfeeding (Table 4), lactation amenorrhea (Table 5), and breast cancer incidence. Compared with women who breastfed but never exclusively, women who breastfed exclusively for more than 18 months had a covariate-adjusted risk of incident premenopausal breast cancer of 0.86 (95% CI, 0.54-1.39; P value for linear trend = .74). There was also no association between duration of lactation amenorrhea and incident disease (HR for >24 months vs <3 months of amenorrhea: 0.92, 95% CI, 0.58-1.44; P value for linear trend = .88).
The association between breastfeeding and breast cancer incidence was modified by a family history of a first-degree relative with breast cancer (P = .03) (Table 6). Among women with a first-degree relative with breast cancer, ever having breastfed was associated with lower breast cancer incidence (covariate-adjusted HR, 0.41; 95% CI, 0.22-0.75) than never having breastfed. Among women without a first-degree family history, having ever breastfed was not associated with breast cancer incidence. In analyses limited to women with only 1 birth, we found a stronger association between ever having breastfed and incident disease among women with a family history of at least 1 first- or second-degree relative with breast cancer than among women without a family history (P value for interaction = .04; family history covariate-adjusted HR, 0.10; 95% CI, 0.02-0.47; no family history covariate-adjusted HR, 0.79; 95% CI, 0.36-1.72, for ever having breastfed compared with never having breastfed).
We further investigated whether the relationship between breastfeeding and incident breast cancer differed by reproductive history. We found no significant interactions between having ever breastfed and parity (likelihood ratio test; P = .72) or age at first birth (likelihood ratio test; P = .88). To test whether breastfeeding the first of several children is associated with a difference in risk, we compared women who had breastfed their first child vs those who had not. We found no association between incident premenopausal breast cancer and having ever breastfed the first child (covariate-adjusted HR, 0.87; 95% CI, 0.63-1.20, compared with not having breastfed the first child). We similarly found no association between duration of breastfeeding for the first child and incident disease (P value for trend = .61).
Use of medication to suppress lactation modified the association between breastfeeding and incident breast cancer. We found a lower incidence of breast cancer among women who had never breastfed but had suppressed lactation than among those who had neither breastfed nor suppressed lactation (age-adjusted HR, 0.58; 95% CI, 0.37-0.90). This association was attenuated in the covariate-adjusted model (HR, 0.65; 95% CI, 0.42-1.02). Among women who had breastfed, cancer incidence was similar regardless of use of lactation suppression (covariate-adjusted HR for women who had suppressed lactation who had breastfed: 0.60; 95% CI, 0.38-0.96; HR for those who had never suppressed lactation who had breastfed: 0.60; 95% CI, 0.41-0.88) compared with women who had neither breastfed nor suppressed lactation.
Finally, we tested whether censoring participants with an additional birth during follow-up affected our results. Inclusion of these participants did not materially alter the observed relationship between having ever breastfed and incident breast cancer risk (covariate-adjusted HR, 0.77; 95% CI, 0.58-1.01).
We found an inverse association between having ever breastfed and incidence of premenopausal breast cancer in a large, prospective cohort study of parous women. The inverse association was restricted to women with a first-degree family history of breast cancer. We found no relationship between incident premenopausal breast cancer and duration or intensity of breastfeeding.
Our study has several strengths. Information on lactation was collected prior to the diagnosis of breast cancer, preventing recall bias. Moreover, detailed data allowed us to test whether duration of exclusive breastfeeding or lactation amenorrhea was related to breast cancer incidence. Other prospective cohort studies were limited to lifetime duration of lactation2,5 or total duration per child.1,6,7 Finally, the size of our study permitted us to examine whether family history modified the association between lactation and incident disease.
Our findings must be interpreted within the context of the study design. Our cohort is comprised entirely of registered nurses, 90% of whom are of self-reported white ancestry, limiting the generalizability of our results to more heterogeneous populations. Observational studies are subject to confounding, and studies of breastfeeding are particularly challenging in this regard. Nevertheless, when we adjusted for established risk factors for breast cancer in our analysis, the association between ever-breastfeeding and incident disease was strengthened, making residual confounding by known risk factors unlikely to explain the observed association. As in any observational study, we cannot exclude the possibility that unmeasured confounding explains the observed difference in incident disease, but such a confounder would have to be strongly associated with both breastfeeding and breast cancer risk to produce an association of this magnitude. Measurement error is also a concern, particularly for recall of breastfeeding history. However, in a validation study, Kark et al10 found that maternally reported breastfeeding duration 20 years after the index birth correlates well with pediatric medical records (Pearson r = 0.82), suggesting that measurement error is unlikely to have materially affected our results.
Several studies have examined the association between lactation and incident premenopausal breast cancer in cohort studies, with differing results. Two studies6,7 have reported an inverse association between lactation and risk of premenopausal or early-onset breast cancer, whereas 2 others1,2 found no association. These conflicting results may reflect differences in age at diagnosis among study populations. In studies that suggest a protective association, participants were considerably younger. This is consistent with multiple cohort studies that have found no association between lactation and postmenopausal breast cancer.1,2,5 Alternatively, it may be that only very long durations of lactation confer protection for older women.11
To our knowledge, our study is the first to examine prospectively duration of exclusive breastfeeding, lactation amenorrhea, and incident breast cancer, and we found no association. Our results suggest that, at the durations of breastfeeding found in our population, anovulation does not mediate observed associations between lactation and breast cancer risk. Others have suggested that failed breastfeeding may be a marker for abnormal breast tissue, conferring an increased risk of cancer.12 We did not assess reasons for weaning, but for each birth, we asked participants, “Did you breastfeed at least 1 month?” Options for response were “yes,” “no, not at all,” and “no, less than 1 month.” If failed milk production were a marker for breast cancer risk, we would expect to see an increased risk of breast cancer among women who breastfed for less than 1 month compared with those who never breastfed. Nevertheless, in our analysis, we found no association between breastfeeding for less than 1 month and incident breast cancer compared with never having breastfed.
We found a reduced risk among women who never breastfed and used medication to suppress lactation. Use of suppression in our study population reflects secular trends in obstetrical care in the United States, with use declining from the 1970s to late 1980s.13- 15 To our knowledge, no other prospective studies have assessed use of suppressive medication, and results from case-control studies have been mixed.16- 20 We speculate that breast cancer incidence may be higher among women who neither breastfed nor used suppressive medication because of disordered involution. During involution, a highly coordinated process of apoptosis, remodeling, and inflammation returns mammary tissue to its prepregnant state.21 In physiologic weaning, this process occurs over weeks or months. By contrast, if a woman does not breastfeed, she experiences abrupt engorgement, and mammary tissue may become progressively inflamed. We hypothesize that both breastfeeding and use of suppressive medications prevent this inflammation, thereby preventing disordered involution. It is also possible that systematic differences among women who did suppress lactation vs those who did not explain the observed association. Further studies are needed to test these hypotheses.
We found a 59% reduction in incidence of premenopausal breast cancer with having ever breastfed among women with a first-degree relative with breast cancer. No other prospective study to our knowledge has examined whether family history modifies the association between breastfeeding and breast cancer risk. Authors of several case-control studies22- 24 have noted stronger inverse associations among women with a family history of breast cancer vs those without, but formal tests of interaction were not always statistically significant. Others have observed no interaction among lactation, family history, and incident disease.25 Authors have also examined whether BRCA1 or BRCA2 mutation carriage modifies the effect of lactation on disease risk, with mixed results.26- 28 Future studies of interactions among breastfeeding history, family history, and genotypes associated with breast cancer risk will be needed to confirm these associations and explore underlying mechanisms.
In conclusion, we found an inverse association between having ever breastfed and the incidence of premenopausal breast cancer in a large prospective cohort of parous women. This association was restricted to women with a first-degree family history of breast cancer. The observed 59% reduction in risk compares favorably with hormonal treatments such as tamoxifen for women at high risk for breast cancer. Moreover, breastfeeding is associated with multiple other health benefits for both mother and child.29 These data suggest that women with a family history of breast cancer should be strongly encouraged to breastfeed.
Correspondence: Alison M. Stuebe, MD, MSc, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, 3010 Old Clinic Bldg, CB No. 7516, Chapel Hill, NC 27599-7516 (email@example.com).
Accepted for Publication: April 28, 2009.
Author Contributions: Dr Stuebe had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analyses. Study concept and design: Stuebe and Michels. Acquisition of data: Michels. Analysis and interpretation of data: Stuebe, Willett, Xue, and Michels. Drafting of the manuscript: Stuebe. Critical revision of the manuscript for important intellectual content: Willett, Xue, and Michels. Statistical analysis: Willett, Xue, and Michels. Obtained funding: Willett and Michels. Administrative, technical, and material support: Stuebe and Xue. Study supervision: Michels.
Financial Disclosure: None reported.
Funding/Support: The NHS II is supported by Public Health Service grant CA50385 from the National Cancer Institute, National Institutes of Health (NIH), US Department of Health and Human Services.
Role of the Sponsors: The NIH did not play any role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.
Previous Presentation: The preliminary findings for this study were presented at the Annual Meeting of the Society for Gynecologic Investigation; March 29, 2008; San Diego, California.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 36
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.